centralcafeen.dk

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

By A Mystery Man Writer

Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets

CityU biologists discover super-enhancers tha

Prevalence and prognostic role of PIK3CA mutations. (a) Bar graph

Etiology of super-enhancer reprogramming and activation in cancer, Epigenetics & Chromatin

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Prevalence and prognostic implications of molecular subtypes within

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers

Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. - Abstract - Europe PMC

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect

Cells, Free Full-Text

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers - Creative Proteomics

Cancers, Free Full-Text

Super-enhancer acquisition drives oncogene expression in triple negative breast cancer